Skip to main content
Admissions guidance, study banks, and career tools — get started on Shalyam
Research News

Yeast Supplement Boosts Cancer-Fighting Immunity in Mice

Mayur Tembhare
  1. Researchers at Trinity College Dublin and University College Dublin found that a yeast-based dietary supplement can strengthen immune cells involved in fighting cancer in mice.

  2. The study used obese laboratory mice, which are prone to having weaker immune systems due to their weight.

  3. The mice were given the supplement for 4-12 weeks and then challenged with different types of cancer cells.

  4. The results showed that the mice who received the supplement had stronger immune responses compared to those who didn't.

Yeast Supplement Boosts Cancer-Fighting Immunity in Mice

Topic: Health

Researchers at Trinity College Dublin and University College Dublin found that a yeast-based dietary supplement can strengthen immune cells involved in fighting cancer. They tested this on obese mice and saw improved results compared to those who didn't receive the supplement.

Researchers at Trinity College Dublin and University College Dublin (UCD) have made an exciting discovery about how to boost our bodies' ability to fight cancer. They found that a yeast-based dietary supplement can strengthen immune cells involved in fighting cancer in mice.

The researchers tested this on obese laboratory mice, which are prone to having weaker immune systems due to their weight. The mice were given the supplement for 4-12 weeks and then challenged with different types of cancer cells. The results showed that the mice who received the supplement had stronger immune responses compared to those who didn't.

This is important because obesity can interfere with our bodies' ability to fight off tumors, making it harder to recover from cancer. The researchers hope that this discovery could lead to new ways to help people with weakened immune systems due to obesity or other factors.

The study was led by Frederick Sheedy and Helen Roche, who are experts in immunology and nutrigenomics respectively. They used a type of yeast called beta-glucan, which is already sold as a dietary supplement and has been shown to be safe for human consumption.

Why It Matters

This discovery could lead to new ways to help people with weakened immune systems due to obesity or other factors, potentially improving cancer treatment outcomes in India where obesity is on the rise.

Key Facts

  • Researchers at Trinity College Dublin and University College Dublin found that a yeast-based dietary supplement can strengthen immune cells involved in fighting cancer in mice.
  • The study used obese laboratory mice, which are prone to having weaker immune systems due to their weight.
  • The mice were given the supplement for 4-12 weeks and then challenged with different types of cancer cells.
  • The results showed that the mice who received the supplement had stronger immune responses compared to those who didn't.
  • The study was published in the scientific journal Cell Reports in 2026.

Key Terms

beta-glucan
a type of yeast used as a dietary supplement that has been shown to be safe for human consumption
trained immunity
the idea that our immune systems can be 'trained' to fight off diseases more effectively through certain interventions

Implications

This discovery could lead to new ways to help people with weakened immune systems due to obesity or other factors, potentially improving cancer treatment outcomes in India where obesity is on the rise.

Source: https://www.sciencedaily.com/releases/2026/08/260821012230.htm

Journal reference:

  1. Anna E. Ledwith, Hannah Prendeville, Cian JH. Horneck Johnston, Stephen P. Cunningham, John P. McGrath, Carrie Corkish, Aaron M. Walsh, Fatma Koc, Hugo Charles-Messance, Vasile Mihai Sularea, Caitlín Ní Chasaide, Heike C. Hawerkamp, David K. Finlay, Lydia Lynch, Kingston H.G. Mills, Catherine Stanton, Helen M. Roche, Frederick J. Sheedy. Yeast β-glucan supplementation supports immunometabolic anti-tumor responses and reverses obesity-induced dysfunction via trained hematopoiesis. Cell Reports, 2026; 45 (7): 117648 DOI: 10.1016/j.celrep.2026.117648

Leave a comment

← All research

Get Exclusive Insights with Every Issue

Join Shalyam Newsletter

Stay ahead in education, research, and innovation—straight to your inbox.